Day 1 :
Keynote Forum
Charles E. Nahabedian
CEO, USA
Keynote: VK Digital Health Expands Telehealth Capabilities while Reducing Healthcare Costs
Time : 09:00- 09:40
Biography:
Charlie Nahabedia holds a BSEE, MSEE, and MBA from Northeastern University and Seton Hall University. Starting his career at Bell Labs and AT&T, he has 50 years in the telecom and computer fields with small and Fortune 100 companies, where he developed and managed the realization of many innovative systems such as the first cordless telephone, first cellular coin telephone aboard a high-speed train, and the interactive-touchscreen kiosk network for Disney World’s EPCOT theme park. He has published over 7 papers, has 2 patents, and received a national award ‘For Outstanding Contribution in A Field of Science’. For 8 years, he has taught graduate entrepreneurial courses at Fairleigh Dickinson University’s Rothman Institute. Charlie, a healthcare idealist, is current CEO of VK Digital Health, and is dedicated to offering innovative healthcare
Abstract:
The global pandemic opened the door to a new era of healthcare where patients no longer need to be physically close to their doctors to get the care they need. VK Digital Health is a company that combines the best of telehealth, telediagnostics, remote patient monitoring (RPM), and care management to improve how physicians remotely treat patients. With interoperability with electronic health record systems and adaptive data analytics, VK can provide unique insights that will continue to improve individual and population healthcare.
The Breeze platform currently includes Breeze360, an RPM and chronic care management portal, and the Breeze Smart Clinic Chair, which features 11 remotely controlled, telediagnostic instruments and a clear, virtual connection to a remote physician for a complete, remote physical exam.
This platform allows telehealth companies to provide more comprehensive care each day and to offer broader services to patients who manage chronic illnesses such as diabetes, heart disease, and cancer.
Early testing has substantiated remote functionality of the system and platform data processing. The results of implementation are reduced healthcare costs for providers and patients; the ability to more accurately diagnose and treat patients with minor or chronic illnesses; and the capacity to prescribe targeted medications while ensuring ongoing medication adherence and monitoring patient wellness.
The Breeze platform, which can be connected via satellite, Wi-Fi, or cellular, to enable care in even the most remote locations, promises to revolutionize how and where telehealth companies give and receive healthcare while decreasing overall healthcare costs